Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies

References

• Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999; 14(4)529–535
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007; 28(31)4551–4560
   PubMed Web of Science ®Google Scholar
• Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, Andia I. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008; 84(2)415–421
   PubMedGoogle Scholar
• Appel TR, Potzsch B, Muller J, von Lindern JJ, Berge SJ, Reich RH. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res 2002; 13(5)522–528
   PubMed Web of Science ®Google Scholar
• Bonnefoy A, Daenens K, Feys HB, De Vos R, Vandervoort P, Vermylen J, Lawler J, Hoylaerts MF. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 2006; 107(3)955–964
   PubMed Web of Science ®Google Scholar
• Braccini F, Dohan DM. The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): Preliminary results. Rev Laryngol Otol Rhinol (Bord) 2007; 128(4)255–260
   PubMedGoogle Scholar
• Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 2005; 76(3)323–328
   PubMedGoogle Scholar
• Choukroun J, Adda F, Schoeffler C, Vervelle A. Une opportunité en paro-implantologie: Le PRF. Implantodontie 2001; 42: 55–62
   Google Scholar
• Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006a; 101(3)299–303
   PubMed Web of Science ®Google Scholar
• Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006b; 101(3)e56–e60
   PubMed Web of Science ®Google Scholar
• Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM. Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?. Rev Laryngol Otol Rhinol (Bord) 2007; 128(1–2)27–32
   PubMedGoogle Scholar
• Clark RA. Fibrin and wound healing. Ann N Y Acad Sci 2001; 936: 355–367
   PubMed Web of Science ®Google Scholar
• Diss A, Dohan DM, Mouhyi J, Mahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: A 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105(5)572–579
   PubMedGoogle Scholar
• Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006a; 101(3)e51–e55
   PubMedGoogle Scholar
• Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006b; 101(3)e45–e50
   PubMed Web of Science ®Google Scholar
• Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006c; 101(3)e37–e44
   PubMed Web of Science ®Google Scholar
• Dohan DM, Choukroun J. PRP, cPRP, PRF, PRG, PRGF, FC. How to find your way in the jungle of platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(3)305–306
   Google Scholar
• Dohan DM, Del Corso M, Charrier J-B. Cytotoxicity analyses of Choukroun's PRF (platelet rich fibrin) on a wide range of human cells: The answer to a commercial controversy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(5)587–593
   PubMedGoogle Scholar
• El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78(4)661–669
   PubMed Web of Science ®Google Scholar
• Everts PA, van Zundert A, Schonberger JP, Devilee RJ, Knape JT. What do we use: Platelet-rich plasma or platelet–leukocyte gel?. J Biomed Mater Res A 2008; 85(4)1135–1136
   PubMedGoogle Scholar
• Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006; 17(2)212–219
   PubMed Web of Science ®Google Scholar
• Italiano JE, Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL. Angiogenesis is regulated by a novel mechanism: Pro- and anti-angiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111(3)1227–1233
   PubMed Web of Science ®Google Scholar
• Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, Varon D, Sixma JJ, Van Aken H, Kehrel BE. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. Faseb J 2003; 17(11)1490–1492
   PubMedGoogle Scholar
• Leitner GC, Gruber R, Neumuller J, Wagner A, Kloimstein P, Hocker P, Kormoczi GF, Buchta C. Platelet content and growth factor release in platelet-rich plasma: A comparison of four different systems. Vox Sang 2006; 91(2)135–139
   PubMedGoogle Scholar
• Martin P, Leibovich SJ. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 2005; 15(11)599–607
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85(6)638–646
   PubMed Web of Science ®Google Scholar
• Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet–leukocyte gel against Staphylococcus aureus. J Orthop Res 2008; 26(3)404–410
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Werther K, Mynster T, Svendsen MN, Rosendahl S, Elley T, Skov F. Bacteria-induced release of white cell—and platelet-derived vascular endothelial growth factor in vitro. Vox Sang 2001; 80(3)170–178
   PubMedGoogle Scholar
• Saadoun AP, Touati B. Soft tissue recession around implants: Is it still unavoidable?—Part II. Pract Proced Aesthet Dent 2007; 19(2)81–87, quiz 88
   PubMedGoogle Scholar
• Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007; 35(2)245–251
   PubMed Web of Science ®Google Scholar
• Sunitha Raja V, Munirathnam Naidu E. Platelet-rich fibrin: Evolution of a second-generation platelet concentrate. Indian J Dent Res 2008; 19(1)42–46
   PubMedGoogle Scholar
• Thor A, Franke-Stenport V, Johansson CB, Rasmusson L. Early bone formation in human bone grafts treated with platelet-rich plasma: Preliminary histomorphometric results. Int J Oral Maxillofac Surg 2007; 36(12)1164–1171
   PubMedGoogle Scholar
• van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 2001; 936: 426–437
   PubMed Web of Science ®Google Scholar
• Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002a; 17(2)184–190
   PubMed Web of Science ®Google Scholar
• Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002b; 30(2)97–102
   PubMed Web of Science ®Google Scholar
• Weibrich G, Kleis WK, Buch R, Hitzler WE, Hafner G. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin Oral Implants Res 2003; 14(2)233–239
   PubMed Web of Science ®Google Scholar
• Weibrich G, Kleis WK, Hitzler WE, Hafner G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: A technical report. Int J Oral Maxillofac Implants 2005; 20(1)118–123
   PubMed Web of Science ®Google Scholar
• Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: Significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 2002; 62(5)343–350
   PubMed Web of Science ®Google Scholar